Language:

Statin therapy is associated with lower prevalence of gut microbiota dysbiosis

Nature (London), 2020-05, Vol.581 (7808), p.310-315 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;COPYRIGHT 2020 Nature Publishing Group ;Copyright Nature Publishing Group May 21, 2020 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-0836 ;ISSN: 1476-4687 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-020-2269-x ;PMID: 32433607

Full text available

Citations Cited by

Actions
1. Add to My Research
2. Remove from My Research
3. E-mail
4. Print
5. Permalink
6. Citation
7. EasyBib
8. EndNote
9. RefWorks
10. Delicious
11. Export RIS
12. Export BibTeX

Title:
Statin therapy is associated with lower prevalence of gut microbiota dysbiosis
Author: Vieira-Silva, Sara ; Falony, Gwen ; Belda, Eugeni ; Nielsen, Trine ; Aron-Wisnewsky, Judith ; Chakaroun, Rima ; Forslund, Sofia K ; Assmann, Karen ; Valles-Colomer, Mireia ; Nguyen, Thi Thuy Duyen ; Proost, Sebastian ; Prifti, Edi ; Tremaroli, Valentina ; Pons, Nicolas ; Le Chatelier, Emmanuelle ; Andreelli, Fabrizio ; Bastard, Jean-Phillippe ; Coelho, Luis Pedro ; Galleron, Nathalie ; Hansen, Tue H ; Hulot, Jean-Sébastien ; Lewinter, Christian ; Pedersen, Helle K ; Quinquis, Benoit ; Rouault, Christine ; Roume, Hugo ; Salem, Joe-Elie ; Søndertoft, Nadja B ; Touch, Sothea ; Dumas, Marc-Emmanuel ; Ehrlich, Stanislav Dusko ; Galan, Pilar ; Gøtze, Jens P ; Hansen, Torben ; Holst, Jens J ; Køber, Lars ; Letunic, Ivica ; Nielsen, Jens ; Oppert, Jean-Michel ; Stumvoll, Michael ; Vestergaard, Henrik ; Zucker, Jean-Daniel ; Bork, Peer ; Pedersen, Oluf ; Bäckhed, Fredrik ; Clément, Karine ; Raes, Jeroen
Subjects: Analysis ; bacterial count ; bacterium ; bacterium identification ; Bacteroides ; Bacteroides - isolation & purification ; Bioinformatics and Systems Biology ; Bioinformatik och systembiologi ; Body mass ; Body mass index ; Body size ; Body weight ; Cardiovascular diseases ; Causes of ; cell ; cell density ; Cohort Studies ; comorbidity ; Constellations ; Control ; correlation analysis ; Cross-Sectional Studies ; Digestive system ; Digestive tract ; disease prevalence ; Diseases ; Distribution ; Dosage and administration ; Drug therapy ; Dysbacteriosis ; Dysbiosis ; Dysbiosis - epidemiology ; Dysbiosis - prevention & control ; Endocrinology and Diabetes ; Endokrinologi och diabetes ; Faecalibacterium ; Faecalibacterium - isolation & purification ; Feces - microbiology ; feces analysis ; Female ; Flora ; Gastrointestinal Microbiome - drug effects ; human ; Humans ; hydroxymethylglutaryl coenzyme A reductase inhibitor ; Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage ; Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology ; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use ; hypercholesterolemia ; Inflammation ; inflammatory bowel disease ; Inflammatory bowel diseases ; Inflammatory Bowel Diseases - microbiology ; Intestinal microflora ; Intestine ; intestine flora ; Life Sciences ; Load ; Male ; metabolic disorder ; Metabolic syndrome ; metagenome ; microbial community ; Microbiomes ; Microbiota ; Microbiota (Symbiotic organisms) ; Microorganisms ; nonhuman ; Obesity ; Obesity - microbiology ; Overweight persons ; prediction ; Prevalence ; Prevalence studies (Epidemiology) ; priority journal ; quantitative analysis ; species diversity ; Statins ; Triglycerides
Is Part Of: Nature (London), 2020-05, Vol.581 (7808), p.310-315
Description: Microbiome community typing analyses have recently identified the Bacteroides2 (Bact2) enterotype, an intestinal microbiota configuration that is associated with systemic inflammation and has a high prevalence in loose stools in humans . Bact2 is characterized by a high proportion of Bacteroides, a low proportion of Faecalibacterium and low microbial cell densities , and its prevalence varies from 13% in a general population cohort to as high as 78% in patients with inflammatory bowel disease . Reported changes in stool consistency and inflammation status during the progression towards obesity and metabolic comorbidities led us to propose that these developments might similarly correlate with an increased prevalence of the potentially dysbiotic Bact2 enterotype. Here, by exploring obesity-associated microbiota alterations in the quantitative faecal metagenomes of the cross-sectional MetaCardis Body Mass Index Spectrum cohort (n = 888), we identify statin therapy as a key covariate of microbiome diversification. By focusing on a subcohort of participants that are not medicated with statins, we find that the prevalence of Bact2 correlates with body mass index, increasing from 3.90% in lean or overweight participants to 17.73% in obese participants. Systemic inflammation levels in Bact2-enterotyped individuals are higher than predicted on the basis of their obesity status, indicative of Bact2 as a dysbiotic microbiome constellation. We also observe that obesity-associated microbiota dysbiosis is negatively associated with statin treatment, resulting in a lower Bact2 prevalence of 5.88% in statin-medicated obese participants. This finding is validated in both the accompanying MetaCardis cardiovascular disease dataset (n = 282) and the independent Flemish Gut Flora Project population cohort (n = 2,345). The potential benefits of statins in this context will require further evaluation in a prospective clinical trial to ascertain whether the effect is reproducible in a randomized population and before considering their application as microbiota-modulating therapeutics.
Publisher: England: Nature Publishing Group
Language: English
Identifier: ISSN: 0028-0836
ISSN: 1476-4687
EISSN: 1476-4687
DOI: 10.1038/s41586-020-2269-x
PMID: 32433607
Source: ProQuest One Psychology
AUTh Library subscriptions: ProQuest Central
Hyper Article en Ligne (HAL) (Open Access)
MEDLINE

Back to results list

Previous Result 6 Next Go to Next page


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Statin therapy is associated with lower prevalence of gut microbiota dysbiosis

Searching Remote Databases, Please Wait